Clinical Trial Update: A Trial of Rosiglitazone for Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing rosiglitazone for ulcerative colitis has been completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: James Lewis | Conditions: Ulcerative Colitis, Inflammatory Bowel Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-12-02